OJOG  Vol.4 No.11 , August 2014
Effect of Diane-35 on Polycystic Ovarian Syndrome of Different Subtypes
ABSTRACT

Objective: To explore the effect of Daine-35 on serum hormone and antral follicle count of different subtypes of polycystic ovarian syndrome (PCOS). Methods: 138 cases of PCOS were recruited and typed according to Rotterdam diagnostic criteria; 78 cases of tubal infertility without hyperandrogenism and menstrual disorders during the same period were collected as control. Serum reproductive hormones including follicle-stimulating hormone (FSH), luteotropic hormone (LH), prolactin (PRL), estradiol (E2), dehydroepiandrosterone (DHEAS), total testosterone (TT) and fast insulin (INS) were determined by chemiluminescent immunoassay. Ovarian antral follicle count was determined by ultrasonography. The effects on above indexes were evaluated for different subtypes of PCOS after 3 cycles of treatment with Daine-35. Results: The cases of Type A and Type B were respectively 43 (31.2%) and 73 (52.9%). They were the most common clinical phenotypes of PCOS in the central region ofChina. Total testosterone (TT) and DHEAS levels of Types A, C and D were higher than those of the control group (p < 0.05). The LH, LH/FSH, INS and HOMA-IR levels in all types of PCOS were higher than those of the control group (p < 0.05). Antral follicle counts of Types A, B and D were more than those of Type C and the control group (p < 0.05). After treatment with Daine-35 for 3 cycles, the serum TT levels of Types A, C and D decreased (p < 0.05). DHEAS values also decreased, but not significantly (p > 0.05). The serum LH and LH/FSH as well as the antral follicle count of all the PCOS types significantly decreased (p < 0.01). Conclusion: Type A and Type B are the most common clinical phenotypes of PCOS in the central region of China. Taking Daine-35 for 3 cycles can significantly reduce the serum androgen, serum LH, LH/FSH ratio, and antral follicle count of different PCOS types.


Cite this paper
Deng, Y. , Deng, X. , Zhou, H. , Hu, Y. , Luo, Q. , Li, J. , Wang, M. , Liu, L. and Xiao, Q. (2014) Effect of Diane-35 on Polycystic Ovarian Syndrome of Different Subtypes. Open Journal of Obstetrics and Gynecology, 4, 659-665. doi: 10.4236/ojog.2014.411092.
References
[1]   Asuncion, M., Calvo, R.M., San Millan, J.L., et al. (2000) A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain. The Journal of Clinical Endocrinology & Metabolism, 85, 2434.

[2]   Zhang, H.Y., Guo, C.X., Zhu, F.F., et al. (2013) Clinical Characteristics, Metabolic Features, and Phenotype of Chinese Women with Polycystic Ovary Syndrome: A Large-Scale Case-Control Study. Archives of Gynecology and Obstetrics, 287, 525-531. http://dx.doi.org/10.1007/s00404-012-2568-z

[3]   Zawadski, J.K. and Dunaif, A. (1992) Diagnostic Criteria for Polycystic Ovary Syndrome: Towards a Rational Approach. In: Dunaif, A., Givens, J.R. and Haseltine, F., Eds., Polycystic Ovary Syndrome, Blackwell Scientific, Boston, 377-384.

[4]   Du, S.M., Ma, M.J., Lin, D.Y., et al. (2013) Consensus on the Women’s Health of PCOS: The Amsterdam ESHRE/ ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Journal of International Reproductive Health/Family Planning, 32, 222-225.

[5]   The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome. Fertility and Sterility, 81, 19-25.

[6]   Zhang, S.D., Zhang, H.L., Li, M., et al. (2014) Compared the Clinical and Biochemical Features of Different Phenotypic Subtype of Polycystic Ovary Syndrome. Journal of Reproductive Medicine, 23, 100-104.

[7]   Zhao, X., Ni, R., Li, L., et al. (2011) Defining Hirsutism in Chinese Women: A Cross-Sectional Study. Fertility and Sterility, 96, 792-796. http://dx.doi.org/10.1016/j.fertnstert.2011.06.040

[8]   Baldani, D.P., Skrgatic, L., et al. (2013) Characteristics of Different Phenotypes of Polycystic Ovary Syndrome Based on the Rotterdam Criteria in the Croatian Population. Collegium Antropologicum, 37, 477-482.

[9]   Hong, Y.Z., Cheng, X.G., Fu, F.Z., et al. (2013) Clinical Characteristics, Metabolic Features, and Phenotype of Chinese Women with Polycystic Ovary Syndrome: A Large-Scale Case-Control Study. Archives of Gynecology and Obstetrics, 287, 525-531. http://dx.doi.org/10.1007/s00404-012-2568-z

[10]   Zhao, Y., Fu, L., Li, R., Wang, L.N., Yang, Y., Liu, N.N., et al. (2012) Metabolic Profiles Characterizing Different Phenotypes of Polycystic Ovary Syndrome: Plasma Metabolomics Analysis. BMC Medicine, 10, 153. http://dx.doi.org/10.1186/1741-7015-10-153

[11]   Cui, L.L. and Chen, Z.J. (2011) Diagnosis Criteria and Guidelines for the Diagnosis and Treatment of PCOS. Journal of International Reproductive Health/Family Planning, 30, 405-408.

[12]   Lin J.F., Li, X. and Zhu, M.W. (2006) Exploration of the Classification of Polycystic Ovarian Syndrome. Chinese Journal of Obstetrics and Gynecology, 41, 684-688.

[13]   Li, M., Song, J., Chen, S.L., Luo, C., Ni, Y.P., Wang, Q.L., et al. (2009) Association of the Clinical Characteristics and the IVF-ET Outcome in Infertile Women with Polycystic Ovarian Syndrome of Different Subtypes. Journal of South Medicine University, 29, 224-227.

[14]   Orio, F., Cascella, T., Giallauria, F., Palomba, S., De Lorenzo, A., Lucci, R., et al. (2006) Polycystic Ovary Syndrome: An Example of Obesity-Related Cardiovascular Complication Affecting Young Women. Monadi Archives for Chest Disease, 66, 48-53.

[15]   Zhao, Y. and Qiao, J. (2013) Ethnic Differences in the Phenotypic Expression of Polycystic Ovary Syndrome. Steroids, 78, 755-760. http://dx.doi.org/10.1016/j.steroids.2013.04.006

[16]   Shi, Y., Gao, X., Sun, X., Zhang, P. and Chen, Z. (2008) Clinical and Metabolic Characteristics of Polycystic Ovary Syndrome without Polycystic Ovary: A Pilot Study on Chinese Women. Fertility and Sterility, 90, 1139-1143. http://dx.doi.org/10.1016/j.fertnstert.2007.07.1375

[17]   Li, X., Guo, Y.R., Lin, J.F., Feng, Y., Billig, H. and Shao, R. (2014) Combination of Diane-35 and Metformin to Treat Early Endometrial Carcinoma in PCOS Women with Insulin Resistance. Journal of Cancer, 5, 173-181. http://dx.doi.org/10.7150/jca.8009

[18]   Zhang, X.Y. (2003) The Utility of Obstetrics and Gynecology. 2nd Edition, 829-831.

[19]   Tartagni, M., Schonauer, L.M., De Salvia, M.A., Cicinelli, E., De Pergola, G. and D’Addario, V. (2000) Comparison of Diane 35 and Diane 35 plus Finasteride in the Treatment of Hirsutism. Fertility and Sterility, 73, 718-723. http://dx.doi.org/10.1016/S0015-0282(99)00633-0

[20]   Palomba, S., Falbo, A., Russo, T., Tolino, A., Orio, F. and Zullo, F. (2010) Pregnancy in Women with Polycystic Ovary Syndrome: The Effect of Different Phenotypes and Features on Obstetric and Neonatal Outcomes. Fertility and Sterility, 94, 1805-1811.
http://dx.doi.org/10.1016/j.fertnstert.2009.10.043

 
 
Top